Featured News & Highlights
Can AI Eliminate “Dead Time” in Drug Development?
FDA’s Emerging Vision for Real-Time Clinical Trials
Over the last 10-15 years, the amount of time spent between clinical trials, including administrative closeout and key decision points, has significantly increased. A new initiative by FDA aims to reduce “dead time” between clinical trial phases.
Solving Operational Complexity in ADC Oncology Trials: From Design to Execution
Many sponsors encounter a consistent challenge: ADC clinical trials introduce a level of operational complexity that goes well beyond traditional oncology trials.
How Bayesian Dose-Finding Designs Can Accelerate Early-Phase Oncology Clinical Research
Historically used more frequently in exploratory analyses, Bayesian approaches are now increasingly recognized as viable frameworks for primary analysis in drug and biologic development—when appropriately designed and justified.
Everest Clinical Research Named Finalist of Fierce Outsourcing Awards for Excellence in Client Partnership
Everest Clinical Research has been named a 2026 finalist in the Excellence in Client Partnership category for the Fierce Outsourcing Awards.
Who Should Own Your Clinical Study URL? A Practical Guide for Sponsors
It sounds like a small administrative detail—but in practice, URL ownership shapes how your trial operates from day one through closeout. It can influence everything from study startup timelines to change control processes, migration costs, and long-term data governance.
Everest Clinical Research and the Friedreich’s Ataxia Research Alliance (FARA) Announce Biostatistics Partnership to Advance Research in Friedreich’s Ataxia
TORONTO and PHILADELPHIA — February 27, 2026 —Everest Clinical Research and the Friedreich’s Ataxia Research Alliance (FARA)…
Everest Clinical Research to Expand Asia Pacific Operations with New Biometrics Team in the Philippines
Expansion will strengthen global biometrics delivery and support continued growth across the globe TORONTO — February 3,…
Everest Clinical Research Welcomes Amy Nguyen as Chief Commercial Officer to Drive Continued Global Growth
TORONTO, December 17, 2025 — Everest Clinical Research, a global, full-service CRO, announces the appointment of Amy…
Everest Strengthens Global Biometrics Capabilities with Expansion in Poland
TORONTO – November 24, 2025 – Everest Clinical Research— a data-driven and quality-focused global CRO — is…